Resistance to Leishmania major in mice is associated with the appearance of distinct T helper type 1 (Th1) and Th2 subsets. T cells from lymph nodes draining cutaneous lesions of resistant mice are primarily interferon gamma (IFN-gamma)-producing Th1 cells. In contrast, T cells from susceptible mice are principally Th2 cells that generate interleukin 4 (IL-4). Although existing evidence is supportive of a role for IFN-gamma in the generation of Th1 cells, additional factors may be required for a protective response to be maintained. A potential candidate is IL-12, a heterodimeric cytokine produced by monocytes and B cells that has multiple effects on T and natural killer cell function, including inducing IFN-gamma production. Using an experimental leishmanial model we have observed that daily intraperitoneal administration at the time of parasite challenge of either 0.33 micrograms IL-12 (a consecutive 5 d/wk for 5 wk) or 1.0 micrograms IL-12 per mouse (only a consecutive 5 d) caused a > 75% reduction in parasite burden at the site of infection, in highly susceptible BALB/c mice. Delay of treatment by 1 wk had less of a protective effect. Concomitant with these protective effects was an increase in IFN-gamma and a decrease in IL-4 production, as measured by enzyme-linked immunosorbent assay of supernatants generated from popliteal lymph node cells stimulated with leishmanial antigen in vitro. The reduction in parasite numbers induced by IL-12 therapy was still apparent at 10 wk postinfection. In addition, we observed that the administration of a rabbit anti-recombinant murine IL-12 polyclonal antibody (200 micrograms i.p. every other day for 25 d) at the time of infection to resistant C57Bl/6 mice exacerbated disease. These effects were accompanied by a shift in IFN-gamma production in vitro by antigen-stimulated lymph node cells indicative of a Th2-like response. These findings suggest that IL-12 has an important role in initiating a Th1 response and protective immunity.
Skip Nav Destination
Article navigation
1 June 1993
Article|
June 01 1993
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
J P Sypek,
J P Sypek
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
C L Chung,
C L Chung
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
S E Mayor,
S E Mayor
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
J M Subramanyam,
J M Subramanyam
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
S J Goldman,
S J Goldman
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
D S Sieburth,
D S Sieburth
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
S F Wolf,
S F Wolf
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
R G Schaub
R G Schaub
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Search for other works by this author on:
J P Sypek
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
C L Chung
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
S E Mayor
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
J M Subramanyam
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
S J Goldman
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
D S Sieburth
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
S F Wolf
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
R G Schaub
Department of Preclinical Biology, Genetics Institute, Inc., Cambridge, Massachusetts 02140.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1993) 177 (6): 1797–1802.
Citation
J P Sypek, C L Chung, S E Mayor, J M Subramanyam, S J Goldman, D S Sieburth, S F Wolf, R G Schaub; Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.. J Exp Med 1 June 1993; 177 (6): 1797–1802. doi: https://doi.org/10.1084/jem.177.6.1797
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement